10 | CMXC Reverse Split/CUSIP Change, 11/5/2024: 1:15 | Steel Reserve | 11/04/2024 5:33:29 PM |
9 | $CMXC News Article - Cell MedX Corp.'s eBalance | whytestocks | 09/01/2020 11:45:52 AM |
8 | $CMXC News Article - Cell MedX Corp. Receives | whytestocks | 06/09/2020 1:40:41 PM |
7 | 3 Penny Stocks Making Big Moves This Week; 1 Over | jonny_red32 | 10/24/2019 12:55:52 PM |
6 | CMXC 24% v737K c1.49 f48M H | znewcar1 | 09/16/2019 5:25:01 PM |
5 | $CMXC News Article - Cell MedX Corp. Provides | whytestocks | 09/12/2019 9:15:42 AM |
4 | $CMXC News Article - Cell Medx Corp (OTCMKTS: | whytestocks | 09/09/2019 12:20:45 PM |
3 | I missed yesterday's trade now I have to buy | kiddme | 06/06/2015 4:43:03 PM |
2 | I've got to be in. GO $CMXC. | kiddme | 06/05/2015 2:45:20 PM |
1 | If CMXC is mining in Phillipines then CMXC will | kiddme | 06/03/2015 9:52:31 PM |
Recent Articles
- Investigation Looms Over Guess?, Inc. Merger with Authentic Brands
- Investigating Jefferies Financial Group Inc.: What You Need to Know
- Molina Healthcare Investors: Important Legal Actions Ahead
- Promising Results for Rinatabart Sesutecan in Cancer Treatment
- Nuvalent Unveils Promising Insights on Neladalkib for ALK Cancer
- United Airlines Incident: Tarmac Collision at O'Hare Airport
- Samsung Chairman's Family Sells Shares to Meet Inheritance Tax
- Clinical Breakthrough: ITM's Promising Trial Results Unveiled
- Celcuity's Promising Phase 1 Trial Results on Prostate Cancer Therapy
- New Findings on Gedatolisib’s Efficacy for Advanced Breast Cancer
- Concerns Raised Over Elon Musk's Striking Compensation Package
- Qustodio: Elevating Digital Child Safety on iPhones in 2025
- Celcuity's Phase 3 VIKTORIA-1 Trial for PIK3CA Mutants Advances
- Innovative Gedatolisib and Darolutamide Study Shows Promise
- New Insights on Gedatolisib's Role in Breast Cancer Treatment
- Meta and Blue Owl Collaborate on $30 Billion AI Data Center
- Kura Oncology's Latest Insights on FTI Program Advancements
- Nvidia's Market Share Plummets: CEO Jensen Huang's Concerns
- Kura Oncology Unveils Promising Data from FTI Programs at ESMO
- Olema Oncology Shares Promising Findings on Palazestrant
- General Oncology's SHARON Trial Yields Encouraging Results
- Revitalizing ER+ Breast Cancer with Palazestrant and Ribociclib
- Corbus Pharmaceuticals Reports Promising Results for CRB-701
- Promising Data on NX-1607: A Breakthrough in Cancer Treatment
- Florida Cancer Specialists Revolutionizing Oncology Research
- Salesforce CEO's Apology Sparks Controversy in Tech Industry
- Significant Progress in Advanced Breast Cancer Treatments with Giredestrant
- Breakthrough in HPV Carcinoma Treatment by SCG Cell Therapy
- Innovative Immunotherapy SCG142 Shows Promise in Cancer Treatment
- Trump's Decision on Ukraine Missiles Revealed After Key Talks
- Kevin O'Leary Highlights Importance of American Dream for Leadership
- Transformational Program for Millennial Professionals Unveiled
- Investigation Launched as PeopleGuru Faces Data Breach Crisis
- Trump Seeks Supreme Court Approval for National Guard in Chicago
- Westhaven Gold Corp. Announces Executive Update and Future Plans
- Trump Commutes Santos' Prison Sentence Amid Public Support
- A New Toolkit to Enhance Executive Function Skills in Education
- Westhaven Gold Announces Leadership Changes and Operations Update
- Aeroméxico's Exciting Global Offering: What You Need to Know
- Investigation Into Luminar Technologies Signals Serious Concerns
- Inquiry into Hasbro Leadership: Legal Investigation Unfolds
- Legal Investigation of CVS/Aetna Medicare Advantage Claims
- Deadline Approaches for Dow Investors in Class Action Case
- Investors Alert: Key Class Action Lawsuit Against V.F. Corporation
- Fluor Corporation Lawsuit Update: Important Investor Info
- Investors Urged to Act Before KBR Class Action Deadline
- Cytokinetics Class Action Lawsuit Update: Important Deadlines
- Important Legal Update for WPP Investors: Key Deadline Approaches
- Molina Healthcare Faces Class Action Lawsuit Amid Financial Turmoil
- Marex Group Faces Class Action Lawsuit Over Financial Misconduct